A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck

Cancer statistics, 1998

1998 • 2,407 citations

Head and Neck Cancer

1993 • 2,263 citations

Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.

1991 • 480 citations

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

1998 • 420 citations

Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion.

1993 • 253 citations

Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

1994 • 249 citations

Docetaxel: an active drug for squamous cell carcinoma of the head and neck.

1996 • 233 citations

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion.

1993 • 137 citations

Phase I Trial of Taxotere: Five-Day Schedule

1992 • 136 citations

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck

1994 • 135 citations

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion.

1993 • 133 citations

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.

1994 • 131 citations

Effects of taxotere on murine and human tumor cell lines

1992 • 129 citations

Phase II evaluation of Taxol in advanced head and neck cancer: an Eastern Cooperative Oncology group trial.

1993 • 91 citations

A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck with correlative laboratory studies.

1995 • 66 citations

Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer

1993 • 55 citations

Recurrent and/or metastatic head and neck squamous cell carcinoma: A clinical, univariate and multivariate analysis of response and survival with cisplatin‐based chemotherapy

1991 • 38 citations

Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancer

1992 • 32 citations

The growth inhibiting effect of docetaxel (Taxotere®) in head and neck squamous cell carcinoma xenografts

1994 • 23 citations

Radiotherapy with Concomitant Chemotherapy for Head and Neck Cancer

1991 • 22 citations

A phase II trial of 10-Ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck

1992 • 19 citations

Chemotherapy in head and neck cancer

1995 • 15 citations

Docetaxel: an interesting new drug for the treatment of head and neck cancers and soft tissue sarcomas

1995 • 7 citations